• Home >
  • Patent Trends across Oncolytic Virotherapy-Genetic Alert

Patent Trends across Oncolytic Virotherapy-Genetic Alert

01-Apr-2016  /  Research Code: D758-00-0D-00-00  /  SKU: HC02860-GL-TA_20521  /  
Region: Global

USD 1,500.00

* Required Fields

USD 1,500.00

PAY BY INVOICE

Be the first to review this product

This edition of the Genetic Alert depicts the current patent landscape and the new life sciences trends across oncolytic virotherapy. Analyst insights on oncolytics viral therapies are also included.The Genetic Alert presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of

Table of Contents

Patent Trends across Oncolytic Virotherapy-Genetic AlertPatent Trend-Based ProfilesOncolytic Viruses and Virotherapy a Rapidly Evolving Space in the Future of Cancer Therapeutics Genelux Corporation has the Highest Number of Granted PatentsKey Granted Patents from the Top Applicants (2012 to 2016) Key Granted Patents from the Top Applicants (2012-2016) Oncolytic Viral Therapies Entering Late Stage Clinical TrialsReovirus Therapy shows Statistical Significance in Reducing Tumor Burden among Ovarian Cancer PatientsCompanion Imaging Modality Works Synergistically with Oncolytic Viral TherapyStrategic PerspectivesStrategic TrendsAppendixIndustry Interactions




Related Research

The Future of Patient Engagement 2.0 in Europe, 2018

Release Date : 30-Nov-18

Region : Europe

PCHA and Partners HealthCare Connected Health Conference, 2018

Release Date : 21-Nov-18

Region : North America

Innovations in Medical Device Cybersecurity Solutions, ECG Monitoring, Artificial Chordae Delivery Systems, Implantable Pulse Generators, Mobile Health Platforms, Teleconsultation Services, and Laser Endomicroscopy

Release Date : 16-Nov-18

Region : Global

Companion Diagnostics: Biomarker Platforms Enabling Precision Medicine

Release Date : 13-Nov-18

Region : Global

Artificial Intelligence Revolutionizing the Pharmaceutical Industry

Release Date : 13-Nov-18

Region : Global

Innovations Involving Use of Quantum Dots in Life Science, Advanced Drug Discovery Platforms, and AAV-vector Manufacturing

Release Date : 09-Nov-18

Region : Global

Growth Opportunities in the Global Medical Imaging Artificial Intelligence Market, Forecast to 2022

Release Date : 30-Oct-18

Region : North America

Innovations in Defibrillators, Disinfection Systems, Orthopedic Implant Designing System, Alzheimer’s Detection, Breast Cancer Diagnosis, and Drug-eluting Stents

Release Date : 19-Oct-18

Region : Global

Unveiling the Potential of Novel Life Sciences Platforms in Stem Cells, Microbiome, Computational Genomics, and Advanced Diagnostics

Release Date : 12-Oct-18

Region : Global

Technology Growth Series--Market Trends and Emerging Opportunities for Visualization

Release Date : 29-Sep-18

Region : Global

Why Frost & Sullivan

Vision & Strategy

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Brand & Demand

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Technology & IP

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

Global Prespective

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.